CIPMX
Price
$21.10
Change
+$0.22 (+1.05%)
Updated
Sep 3 closing price
Net Assets
1.13B
RPTIX
Price
$101.26
Change
-$0.38 (-0.37%)
Updated
Sep 4 closing price
Net Assets
22.01B
Interact to see
Advertisement

CIPMX vs RPTIX

CIPMX vs RPTIX Comparison Chart in %
View a ticker or compare two or three
VS
CIPMX vs. RPTIX commentary
Sep 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIPMX is a Hold and RPTIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 22B vs. CIPMX (1.13B). RPTIX pays higher dividends than CIPMX: RPTIX (0.11) vs CIPMX (0.00). CIPMX was incepted earlier than RPTIX: CIPMX (18 years) vs RPTIX (11 years). CIPMX (1.11) is less costly to investors than RPTIX (0.63). CIPMX is a more actively managed with annual turnover of: 44.00 vs. RPTIX (31.50). CIPMX has a lower initial minimum investment than RPTIX: CIPMX (10000) vs RPTIX (500000). RPTIX annual gain was more profitable for investors over the last year : -2.09 vs. CIPMX (-10.62). RPTIX return over 5 years is better than : -23.27 vs. CIPMX (-31.83).
CIPMXRPTIXCIPMX / RPTIX
Total Expense Ratio1.110.63176%
Annual Report Gross Expense Ratio1.110.63176%
Fund Existence18 years11 years-
Gain YTD6.2602.931214%
Front LoadN/AN/A-
Min. Initial Investment100005000002%
Min. Initial Investment IRAN/AN/A-
Net Assets1.13B22B5%
Annual Yield % from dividends0.000.11-
Returns for 1 year-10.62-2.09507%
Returns for 3 years-7.28-0.431,703%
Returns for 5 years-31.83-23.27137%
Returns for 10 years38.4629.47130%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGEFX15.240.11
+0.70%
Baillie Gifford International Growth 4
WSGRX12.640.07
+0.56%
Nomura Small Cap Growth R
TSPRX5.14N/A
N/A
Transamerica Small Cap Growth R
MNBWX20.16N/A
N/A
Manning & Napier Pro-Blend Extnd Term W
PCUZX76.72N/A
N/A
T. Rowe Price U.S. Equity Research Z